The advancement and reappearance of carcinoma of the liver, carcinoma of the prostate, pancreatic ductal adenocarcinoma, and multiple additional malignancies have been linked to overexpression of BUB1B [75]. This evidence concerns the gene BUB1B and prostate carcinoma.